Skip to main content
MIST logo

MIST · Milestone Pharmaceuticals Inc. · Analyst Estimates

Track MIST — free
$0.80 -0.01 (-1.72%)
Market Cap
$98.15M
Shares
124.50M
Volume · Oct 2 277.42K Avg daily vol (3M) 1.42M

Analyst Estimates

Compare analyst forecasts for Milestone Pharmaceuticals Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 07:44 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.9
-0.838
-0.77
—
-0.83
-0.9725
-0.838
-0.9725
— — — —
EPS
analysts
Publication date not stated
— — —
5
— — — —
3
3
1
1
Revenue
USD
Publication date not stated
2800000
3828140
6000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
7
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.96
-0.772
-0.54
—
-0.9075
-1.045
-0.772
-1.045
— — — —
EPS
analysts
Publication date not stated
— — —
5
— — — —
2
2
2
2
Revenue
USD
Publication date not stated
11000000
22066430
34600000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
7
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.23
-0.212
-0.2
—
-0.21
-0.21
-0.212
-0.21
— — — —
EPS
analysts
Publication date not stated
— — —
5
— — — —
2
2
2
2
Revenue
USD
Publication date not stated
800000
1142860
2000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
7
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.27
-0.226
-0.2
—
-0.23
-0.23
-0.226
-0.23
— — — —
EPS
analysts
Publication date not stated
— — —
5
— — — —
2
2
1
1
Revenue
USD
Publication date not stated
1100000
1957140
3000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
7
— — — — — — — —
Key facts CIK 1408443 CUSIP 59935V107 13F (30d) 2 filings 2 filers Visit website Investor relations